SCORE: Business Start-up Bootcamp

BioCT Innovation Commons 93 Shennecossett Road, Groton, United States

5 part series from February 28th to March 28th at CURE Innovation Commons. Registration and additional information here.

SCORE: Business Start-up Bootcamp

BioCT Innovation Commons 93 Shennecossett Road, Groton, United States

5 part series from February 28th to March 28th at CURE Innovation Commons. Registration and information here.

SCORE: Business Start-up Bootcamp

BioCT Innovation Commons 93 Shennecossett Road, Groton, United States

5 part series from February 28th to March 28th at CURE Innovation Commons. The March 21st program has been postponed to April 4th due to the foretasted snow. Registration and additional information here.

BioCT Innovation Commons 93 Shennecossett Road, Groton, United States

There will be lots of great information to support starting or growing your business. Participants will be able to schedule 45-minute appointments with innovative and inspiring mentors. Refreshments, resources and networking are also key parts of this event. Join us to solve your start-up challenges while making great connections! Whether you are 'stuck' with your […]

Free

SCORE: Business Start-up Bootcamp

BioCT Innovation Commons 93 Shennecossett Road, Groton, United States

5 part series from February 28th to March 28th at CURE Innovation Commons. Registration and additional information here.

Simple Steps for Starting Your Business

BioCT Innovation Commons 93 Shennecossett Road, Groton, United States

Calling all aspiring entrepreneurs! SCORE of Southeastern Connecticut, with the support of IGNITE Thames River, launches Simple Steps for Starting Your Business: a FREE five-session small business workshop series. You have goals to achieve with your business idea, and building a solid foundation will help you. The five workshops in this free series will help you position your […]

Free

Bioscience ClubhouseCT Features: The Story of Cybrexa with Per Hellsund, President & CEO

Cybrexa Therapeutics is an oncology-focused biotechnology company working to create novel therapeutics with a markedly enhanced therapeutic index. Its first class of new agents will target DNA repair, with a focus on the creation of new classes of radio- and chemo-sensitizers, which will target a wide range of solid tumors. These new agents will allow the […]